Gyre Therapeutics (GYRE) Return on Equity [ROE] (2011 - 2026)
Gyre Therapeutics (GYRE) posted Return on Equity [ROE] of -21.08% for Q2 2026, down 30.89 percentage points from 9.82% a year earlier and down 6.82 percentage points from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025, Gyre Therapeutics' Return on Equity [ROE] came in at 20.10%, down 51.86 percentage points from FY2024.
- Annual Return on Equity [ROE] shows a five-year change of +98.00 percentage points (FY2020 to FY2025).
- In prior years, Gyre Therapeutics' Return on Equity [ROE] was 71.97% in FY2024 (+270.38 pp), -198.41% in FY2023 (-204.96 pp), 6.55% in FY2022 (+136.31 pp) and -129.76% in FY2021 (-51.86 pp).
- The Q2 2026 figure stands as the lowest quarterly Return on Equity [ROE] since Q3 2024.
- On a year-over-year basis, Return on Equity [ROE] has declined in each of the last three quarters, with an average year-over-year change of +51.05 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q1 2023, with a gain of 215.79 percentage points; the weakest was Q1 2024, with a drop of 186.15 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -14.25% (Q1 2026), 6.07% (Q4 2025) and 8.12% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 4.97% |
| 10 | Gyre Therapeutics | 742.24 Mn | 544.95 Mn | 26.90 Mn | -21.08% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -21.08% |
| Mar 31, 2026 | -14.25% |
| Dec 31, 2025 | 6.07% |
| Sep 30, 2025 | 8.12% |
| Jun 30, 2025 | 9.82% |
| Mar 31, 2025 | 30.59% |
| Dec 31, 2024 | 26.66% |
| Sep 30, 2024 | -87.22% |
| Jun 30, 2024 | -86.75% |
| Mar 31, 2024 | -155.30% |
| Dec 31, 2023 | -172.22% |
| Sep 30, 2023 | -15.24% |
| Jun 30, 2023 | -32.03% |
| Mar 31, 2023 | 30.85% |
| Dec 31, 2022 | 8.49% |
| Sep 30, 2022 | 21.92% |
| Jun 30, 2022 | -15.96% |
| Mar 31, 2022 | -184.94% |
| Dec 31, 2021 | -146.31% |
| Sep 30, 2021 | -118.59% |
API Access
Gyre Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();